Masahiro Maruyama

Dr. Masahiro Maruyama

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
Stuart B GoodmanStuart B Goodman
Stuart B Goodman
MMMasahiro Maruyama
Masahiro Maruyama
Osteonecrosis of the epiphyseal and metaphyseal regions of major weight-bearing bones of the extremities is a condition that is associated with local death of bone cells and marrow in the afflicted compartment. Chronic inflammation is a prominent feature of osteonecrosis. If the persistent inflammation is not resolved, this process will result in progressive collapse and subsequent degenerative arthritis. In the pre-collapse stage of osteonecrosis, attempt at joint preservation rather than joint replacement in this younger population with osteonecrosis is a major clinical objective. In this regard, core decompression, with/without local injection of bone marrow aspirate concentrate (BMAC), is an accepted and evidence-based method to help arrest the progression and improve the outcome of early-stage osteonecrosis. However, some patients do not respond favorably to this treatment. Thus, it is prudent to consider strategies to mitigate chronic inflammation concurrent with addressing the deficiencies in osteogenesis and vasculogenesis in order to save the affected joint. Interestingly, the processes of inflammation, osteonecrosis, and bone healing are highly inter-related. Therefore, modulating the biological processes and crosstalk among cells of the innate immune system, the mesenchymal stem cell-osteoblast lineage and others are important to providing the local microenvironment for resolution of inflammation and subsequent repair. This review summarizes the clinical and biologic principles associated with osteonecrosis and provides potential cutting-end strategies for modulating chronic inflammation and facilitating osteogenesis and vasculogenesis using local interventions. Although these studies are still in the preclinical stages, it is hoped that safe, efficacious, and cost-effective interventions will be developed to save the host’s natural joint.

1 March 2018 in Journal of Orthopaedic Science
Verified
Journal Article
Open access
MMMasahiro Maruyama
Masahiro Maruyama
MTMasatoshi Takahara
Masatoshi Takahara
HSHiroshi Satake
Hiroshi Satake
Osteochondritis dissecans (OCD) of the humeral capitellum is a critical elbow injury in adolescent overhead throwing athletes. However, its etiology remains unknown. Medical examinations using ultrasonography found that the prevalence of capitellar OCD among adolescent baseball players was approximately from 1% to 3%. A plain anteroposterior radiograph with the elbow in 45° of flexion is essential for the diagnosis of an OCD lesion. The stability of OCD lesions is evaluated on plain radiographs, computed tomography, and magnetic resonance imaging (MRI). Imaging features of the unstable lesions are an epiphyseal closure of the capitellum or a lateral epicondyle, a displaced fragment, or irregular contours of the articular surface and a high signal interface on T2-weighted MRI. A stable lesion has the potential to be healed with conservative treatment. By contrast, surgical treatment should be considered if there is no radiographic improvement within 3 months. In addition, surgery should be performed for the lesions that cause pain during daily activities, have a locking phenomenon, or which are assessed by imaging as obviously unstable. Arthroscopic debridement/loose body removal can be performed for small lesions (≤12 mm in diameter). For large lesions (>12 mm), preservation and/or reconstruction of the articular surface should be selected, such as bone-peg fixation of the lateral part of the fragment and osteochondral autograft transplantation (OAT) from the knee. In the future directions, there is no comparative study of OAT from the knee and rib. In addition, little is known about its long-term outcome, or resulting osteoarthritis. A recent meta-analysis showed that grafts harvested from the knee may lead to donor site morbidity (7.8%). Thus, a novel cartilage tissue engineering approach is anticipated.

11 April 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
EHElijah Ejun Huang
Elijah Ejun Huang
Ning ZhangNing Zhang
Ning Zhang
HSHuaishuang Shen
Huaishuang Shen
XLXueping Li
Xueping Li
MMMasahiro Maruyama
Masahiro Maruyama
Stuart B GoodmanStuart B Goodman
Stuart B Goodman
A critical-size bone defect is a challenging clinical problem in which a gap between bone ends will not heal and will become a nonunion. The current treatment is to harvest and transplant an autologous bone graft to facilitate bone bridging. To develop less invasive but equally effective treatment options, one needs to first have a comprehensive understanding of the bone healing process. Therefore, it is imperative to leverage the most advanced technologies to elucidate the fundamental concepts of the bone healing process and develop innovative therapeutic strategies to bridge the nonunion gap. In this review, we first discuss the current animal models to study critical-size bone defects. Then, we focus on four novel analytic techniques and discuss their strengths and limitations. These four technologies are mass cytometry (CyTOF) for enhanced cellular analysis, imaging mass cytometry (IMC) for enhanced tissue special imaging, single-cell RNA sequencing (scRNA-seq) for detailed transcriptome analysis, and Luminex assays for comprehensive protein secretome analysis. With this new understanding of the healing of critical-size bone defects, novel methods of diagnosis and treatment will emerge.

6 December 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
TLTzuhua Lin
Tzuhua Lin
JPJukka Pajarinen
Jukka Pajarinen
YKYusuke Kohno
Yusuke Kohno
JHJhih-Fong Huang
Jhih-Fong Huang
MMMasahiro Maruyama
Masahiro Maruyama
Stuart B GoodmanStuart B Goodman
Stuart B Goodman
Mesenchymal stem cell (MSC)‐mediated immunomodulation affects both innate and adaptive immune systems. These responses to environmental cues, such as pathogen‐associated molecular patterns, damage‐associated molecular patterns, or proinflammatory cytokines, are crucial for resolution of inflammation, as well as successful tissue healing and regeneration. We observed that intermittent, repeated exposure of MSCs to LPS induced stronger NF‐κB activation than singular stimulation. A similar phenomenon, named innate immune memory or trained immunity, has been reported with macrophages. However, the potential regulation of “immune memory” in nonclassic immune cells, such as MSCs, has not been reported. In the current study, we chose IFN‐γ plus TNF‐α restimulation‐induced iNOS expression as a model of MSC activation, because IFN‐γ and TNF‐α play crucial roles in MSC‐mediated immunomodulation. The iNOS expression was enhanced in LPS‐trained MSCs, 3 d after a washout period following primary stimulation. LPS‐trained MSCs enhanced the anti‐inflammatory (arginase 1 and CD206) marker expression, but decreased the proinflammatory marker (TNF‐α, IL‐lβ, iNOS, and IL‐6) expression using an MSC‐macrophage coculture model. In contrast, LPS‐trained MSCs demonstrated a defective regulation on CD4 T‐cell proliferation. Mechanistic studies suggested that histone methylation and the JNK pathway are involved in LPS‐trained immunomodulation in MSCs. Our results demonstrate differential immunomodulatory effects of trained MSCs on macrophages and T cells. These immunomodulatory consequences are critical, because they will have a major impact on current MSC‐based cell therapies.—Lin, T., Pajarinen, J., Kohno, Y., Huang, J.‐F., Maruyama, M., Romero‐Lopez, M., Nathan, K., Yao, Z., Goodman, S. B. Trained murine mesenchymal stem cells have anti‐inflammatory effect on macrophages, but defective regulation on T‐cell proliferation. FASEB J. 33,4203–4211 (2019). www.fasebj.org


1 May 2021 in Journal of Orthopaedic Translation
Verified
Journal Article
Open access
MMMasahiro Maruyama
Masahiro Maruyama
CPChi-Chun Pan
Chi-Chun Pan
SMSeyedsina Moeinzadeh
Seyedsina Moeinzadeh
HSHunter W. Storaci
Hunter W. Storaci
RGRoberto Alfonso Guzman
Roberto Alfonso Guzman
YYYunzhi Peter Yang
Yunzhi Peter Yang
Background/Objective: Core decompression (CD) with scaffold and cell-based therapies is a promising strategy for providing both mechanical support and regeneration of the osteonecrotic area for early stage osteonecrosis of the femoral head (ONFH). We designed a new 3D printed porous functionally-graded scaffold (FGS) with a central channel to facilitate delivery of transplanted cells in a hydrogel to the osteonecrotic area. However, the optimal porous structural design for the FGS for the engineering of bone in ONFH has not been elucidated. The aim of this study was to fabricate and evaluate two different porous structures (30% or 60% porosity) of the FGSs in corticosteroid-associated ONFH in rabbits. Two different FGSs with 30% or 60% porosity containing a 1-mm central channel were 3D printed using polycaprolactone and β-tricalcium phosphate. The FGS was 3-mm diameter and 32-mm length and was composed of three segments: 1-mm in length for the non-porous proximal segment, 22-mm in length for the porous (30% versus 60%) middle segment, and 9-mm in length for the 15% porous distal segment. Eighteen male New Zealand White rabbits were given a single dose of 20 ​mg/kg methylprednisolone acetate intramuscularly. Four weeks later, rabbits were divided into three groups: the CD group, the 30% porosity FGS group, and the 60% porosity FGS group. In the CD group, a 3-mm diameter drill hole was created into the left femoral head. In the FGS groups, a 30% or 60% porosity implant was inserted into the bone tunnel. Eight weeks postoperatively, femurs were harvested and microCT, mechanical, and histological analyses were performed. The actual porosity and pore size of the middle segments were 26.4% ​± ​2.3% and 699 ​± ​56 ​μm in the 30% porosity FGS, and 56.0% ​± ​4.5% and 999 ​± ​71 ​μm in the 60% porosity FGS, respectively using microCT analysis. Bone ingrowth ratio in the 30% porosity FGS group was 73.9% ​± ​15.8%, which was significantly higher than 39.5% ​± ​13.0% in the CD group on microCT (p ​< ​0.05). Bone ingrowth ratio in the 60% porosity FGS group (61.3% ​± ​30.1%) showed no significant differences compared to the other two groups. The stiffness at the bone tunnel site in the 30% porosity FGS group was 582.4 ​± ​192.3 ​N/mm3, which was significantly higher than 338.7 ​± ​164.6 ​N/mm3 in the 60% porosity FGS group during push-out testing (p ​< ​0.05). Hematoxylin and eosin staining exhibited thick and mature trabecular bone around the porous FGS in the 30% porosity FGS group, whereas thinner, more immature trabecular bone was seen around the porous FGS in the 60% porosity FGS group. These findings indicate that the 30% porosity FGS may enhance bone regeneration and have superior biomechanical properties in the bone tunnel after CD in ONFH, compared to the 60% porosity FGS. The translational potential of this article: This FGS implant holds promise for improving outcomes of CD for early stage ONFH.